August 7, 2026

PureTech Health plc (PRTC): Investor Outlook Amidst Innovative Biotech Developments

In the dynamic world of biotechnology, PureTech Health plc (PRTC) stands as a notable player, focusing on pioneering medical solutions that address significant unmet needs. With..

Organogenesis Holdings Inc. (ORGO) Stock Analysis: Potential 24% Upside for Investors

Organogenesis Holdings Inc. (NASDAQ: ORGO), a key player in the regenerative medicine sector, has captured the attention of investors looking for hidden gems in the healthcare..

Oric Pharmaceuticals, Inc. (ORIC) Stock Analysis: A Promising Biotech with 60% Upside Potential

Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to combat cancer resistance mechanisms. Headquartered..

COMPASS Pathways (CMPS) Investor Outlook: Uncovering a 75% Potential Upside in Mental Health Innovation

Investors eyeing the healthcare sector, particularly those with an interest in innovative mental health solutions, should closely examine COMPASS Pathways Plc (NASDAQ: CMPS). This UK-based biotechnology..

Emergent BioSolutions Inc. (EBS): Investor Outlook Reveals 125.99% Potential Upside

Emergent BioSolutions Inc. (NYSE: EBS) is a compelling player in the healthcare sector, specializing in drug manufacturing with a focus on specialty and generic solutions. At..

Tilray Brands, Inc. (TLRY) Stock Analysis: Exploring a 76.66% Potential Upside Amidst Market Challenges

For investors with a keen eye on healthcare stocks, Tilray Brands, Inc. (NASDAQ: TLRY) presents a compelling case. With a market capitalization of $548.15 million, this..

SIGA Technologies Inc. (SIGA) Stock Analysis: Assessing the Growth Potential Amidst Healthcare Sector Challenges

Investors eyeing the healthcare sector, particularly within the specialty and generic drug manufacturing space, may find SIGA Technologies Inc. (NASDAQ: SIGA) an intriguing prospect. With a..

MeiraGTx Holdings plc (MGTX) Stock Analysis: Exploring a 128.97% Potential Upside in the Biotech Arena

For investors eyeing opportunities in the biotechnology sector, MeiraGTx Holdings plc (NASDAQ: MGTX) presents a compelling case with its significant potential upside and a robust pipeline..

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating Challenges with Innovative Medical Solutions

Treace Medical Concepts, Inc. (NASDAQ: TMCI), a player in the healthcare sector’s medical devices industry, is making waves with its innovative solutions for bunion and foot..

Humacyte, Inc. (HUMA): Investor Outlook on a High-Stakes Biotech with 188.90% Potential Upside

As Humacyte, Inc. (NASDAQ: HUMA) continues to trail blaze in the healthcare sector with its pioneering biotechnology, investors are weighing the pros and cons of this..

Abivax SA (ABVX) Stock Analysis: A 27.62% Potential Upside in the Biotechnology Sector

Investors with a keen eye on the healthcare sector may find Abivax SA (ABVX) to be an intriguing opportunity, particularly within the biotechnology industry. Headquartered in..

Myriad Genetics, Inc. (MYGN) Stock Analysis: Navigating Through a Challenging Landscape with 69.36% Potential Upside

For investors eyeing opportunities in the healthcare sector, Myriad Genetics, Inc. (NASDAQ: MYGN) presents a complex yet potentially rewarding scenario. This molecular diagnostics and precision medicine..

Precigen, Inc. (PGEN) Stock Analysis: Strong Growth Potential with an 80% Upside

For investors with a keen eye on the biotechnology sector, Precigen, Inc. (PGEN) presents a fascinating opportunity. This U.S.-based biopharmaceutical company is at the forefront of..

OrthoPediatrics Corp. (KIDS) Investor Outlook: A 10.97% Potential Upside with Solid Buy Ratings

OrthoPediatrics Corp. (NASDAQ: KIDS), a prominent player in the medical device industry focused on pediatric orthopedics, is capturing the attention of investors with its promising growth..

Investiva S.A. (IVA) Stock Analysis: Exploring a 219% Potential Upside in Biotech

Inventiva S.A. (IVA), a French biotechnology firm, is carving a niche in the healthcare sector with its innovative focus on developing oral small molecule therapies. The..

Akso Health Group (AHG) Stock Analysis: Navigating Uncertain Waters in Medical Distribution

Akso Health Group (AHG), a player in the healthcare sector, operates within the medical distribution industry, boasting a market cap of $1.13 billion. Based in Qingdao,..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: A Biotech Stock with 76% Potential Upside

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a promising player in the biotechnology sector, is capturing the attention of investors with its strong pipeline of innovative therapies and..

AngioDynamics, Inc. (ANGO) Stock Analysis: Uncovering a 32% Potential Upside with Robust Buy Ratings

AngioDynamics, Inc. (NASDAQ: ANGO), a prominent player in the healthcare sector focusing on medical instruments and supplies, presents an intriguing opportunity for investors seeking growth in..

Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Exploring a 27.94% Potential Upside in the Biotech Sector

Rapport Therapeutics, Inc. (NASDAQ: RAPP) is making waves in the biotechnology sector with its focus on developing innovative treatments for central nervous system (CNS) disorders. With..

Praxis Precision Medicines, Inc (PRAX): Investor Outlook on a Biotech Powerhouse with 71.91% Upside Potential

Praxis Precision Medicines, Inc (NASDAQ: PRAX) is capturing the attention of investors with its strategic focus on developing breakthrough therapies for central nervous system (CNS) disorders...

Search

Funds

August 7, 2026

Search

Funds

August 7, 2026

FTSE 100

Funds